89 related articles for article (PubMed ID: 29594196)
1. Hepatitis E virus infection and risk of hepatocellular carcinoma: A systematic review and meta-analysis.
Yin X; Kan F
Cancer Epidemiol; 2023 Dec; 87():102457. PubMed ID: 37797398
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of interleukin-18 in diabetic retinopathy patients: A meta-analysis.
Jiang Y; Zhou L; Yao L
Eur J Ophthalmol; 2023 Nov; 33(6):2259-2266. PubMed ID: 36974472
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D Status in Patients with Primary Antiphospholipid Syndrome (PAPS): A Systematic Review and Meta-Analysis.
Islam MA; Ahmed S; Sultana S; Alam SS; Hossan T; Gouda W; Alsaqabi F; Hassan R; Kotyla PJ
Antibodies (Basel); 2024 Mar; 13(1):. PubMed ID: 38534213
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of Patients With Fibrolamellar Hepatocellular Carcinoma Versus Conventional Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Njei B; Konjeti VR; Ditah I
Gastrointest Cancer Res; 2014 Mar; 7(2):49-54. PubMed ID: 24799971
[TBL] [Abstract][Full Text] [Related]
5. Statin Use and Hepatocellular Carcinoma Risk: A Comprehensive Meta- Analysis and Systematic Review.
Hashemi Rafsanjani MR; Rahimi R; Heidari-Soureshjani S; Darvishi M; Adeli OA; Abbaszadeh S
Recent Pat Anticancer Drug Discov; 2024 Jan; ():. PubMed ID: 38284728
[TBL] [Abstract][Full Text] [Related]
6. Platelet count as a predictor of vascular invasion and extrahepatic metastasis in hepatocellular carcinoma: A systematic review and meta-analysis.
Pang Q; Gong X; Pan H; Wang Y; Hu X; Liu H; Jin H
Heliyon; 2024 Mar; 10(6):e28173. PubMed ID: 38545227
[TBL] [Abstract][Full Text] [Related]
7. Role of Galectins in the Liver Diseases: A Systematic Review and Meta-Analysis.
An Y; Xu S; Liu Y; Xu X; Philips CA; Chen J; Méndez-Sánchez N; Guo X; Qi X
Front Med (Lausanne); 2021; 8():744518. PubMed ID: 34778306
[No Abstract] [Full Text] [Related]
8. The association between zinc and prostate cancer development: A systematic review and meta-analysis.
Shahrokhi Nejad S; Golzari Z; Zangiabadian M; Salehi Amniyeh Khozani AA; Ebrahimi R; Nejadghaderi SA; Aletaha A
PLoS One; 2024; 19(3):e0299398. PubMed ID: 38507438
[TBL] [Abstract][Full Text] [Related]
9. C-Reactive Protein as a Marker of Inflammation in Children and Adolescents with Metabolic Syndrome: A Systematic Review and Meta-Analysis.
Podeanu MA; Turcu-Stiolica A; Subțirelu MS; Stepan MD; Ionele CM; Gheonea DI; Vintilescu BȘ; Sandu RE
Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38001962
[TBL] [Abstract][Full Text] [Related]
10. Integrated Predictors by Propensity Scoring With Tumor Markers and Plasma Levels of microRNA-21-5p, IL-17, and IL-10 Complement Early Detection of Hepatocellular Carcinoma in Patients With Liver Cirrhosis.
Machida M; Ambo M; Mishina R; Hada N; Tachibana F; Yamashita M; Konda A; Tsuji K
Technol Cancer Res Treat; 2023; 22():15330338231212084. PubMed ID: 37960842
[No Abstract] [Full Text] [Related]
11. Dynamic Changes of Cytokine Profiles and Their Correlation With Tumor Recurrence Following Thermal Ablation in Hepatocellular Carcinoma.
Guo D; Qin L; Sun J; Li K; Zang C; Wang Q; Qiao W; Liu B; Zhao Y; Zhang Y
Technol Cancer Res Treat; 2023; 22():15330338231190644. PubMed ID: 37525880
[TBL] [Abstract][Full Text] [Related]
12. Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma.
Chamseddine S; Mohamed YI; Lee SS; Yao JC; Hu ZI; Tran Cao HS; Xiao L; Sun R; Morris JS; Hatia RI; Hassan M; Duda DG; Diab M; Mohamed A; Nassar A; Datar S; Amin HM; Kaseb AO
Oncology; 2023; 101(11):730-737. PubMed ID: 37467732
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for Hepatocellular Carcinoma in the Setting of Liver Transplantation: A Review.
Lominadze Z; Hill K; Shaik MR; Canakis JP; Bourmaf M; Adams-Mardi C; Abutaleb A; Mishra L; Shetty K
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768686
[TBL] [Abstract][Full Text] [Related]
14. Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace.
Pocino K; Stefanile A; Basile V; Napodano C; D'Ambrosio F; Di Santo R; Callà CAM; Gulli F; Saporito R; Ciasca G; Equitani F; Basile U; Marino M
J Pers Med; 2022 Dec; 13(1):. PubMed ID: 36675666
[TBL] [Abstract][Full Text] [Related]
15. Elevated Levels of IL-33, IL-17 and IL-25 Indicate the Progression from Chronicity to Hepatocellular Carcinoma in Hepatitis C Virus Patients.
Askoura M; Abbas HA; Al Sadoun H; Abdulaal WH; Abu Lila AS; Almansour K; Alshammari F; Khafagy ES; Ibrahim TS; Hegazy WAH
Pathogens; 2022 Jan; 11(1):. PubMed ID: 35056005
[TBL] [Abstract][Full Text] [Related]
16. Targeting T Cell Subtypes for NAFLD and NAFLD-Related HCC Treatment: An Opinion.
Zhang C; Yang M
Front Med (Lausanne); 2021; 8():789859. PubMed ID: 34869507
[No Abstract] [Full Text] [Related]
17. Exosomal microRNA-4661-5p-based serum panel as a potential diagnostic biomarker for early-stage hepatocellular carcinoma.
Cho HJ; Baek GO; Seo CW; Ahn HR; Sung S; Son JA; Kim SS; Cho SW; Jang JW; Nam SW; Cheong JY; Eun JW
Cancer Med; 2020 Aug; 9(15):5459-5472. PubMed ID: 32537885
[TBL] [Abstract][Full Text] [Related]
18. Modeling of the immune response in the pathogenesis of solid tumors and its prognostic significance.
Zadka Ł; Grybowski DJ; Dzięgiel P
Cell Oncol (Dordr); 2020 Aug; 43(4):539-575. PubMed ID: 32488850
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of serum interleukin-10 levels in hepatocellular carcinoma patients: a systematic review and meta-analysis.
Shakiba E; Ramezani M; Sadeghi M
Clin Exp Hepatol; 2018 Mar; 4(1):35-40. PubMed ID: 29594196
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
